Development of national performance measures on the prevention and treatment of venous thromboembolism.

Journal of Thrombosis and Thrombolysis
Dale W Bratzler

Abstract

Venous thromboembolism (VTE) remains a significant public health problem in the United States, particularly for hospitalized patients. Approximately two-thirds of all VTE events are associated with recent hospitalization. Despite the well-known risks of VTE, multiple studies have demonstrated underuse of VTE prophylaxis and clinicians often do not provide evidence-based care for those patients with confirmed VTE. In January 2005, the National Quality Forum initiated a project to develop national consensus standards on organization policies, preferred practices, and performance measures for the prevention and treatment of VTE. In addition to the organizational policy statement and 17 preferred practices, eight national performance measures addressing various aspects of VTE prevention and care have been endorsed. There is now a broad consensus on standardized measures of quality for the prevention and treatment of VTE, and a national commitment to collect and publicly report data on the quality of care for this important health problem.

References

Oct 25, 1991·Annals of Internal Medicine·F A AndersonN A Patwardhan
Jul 1, 1996·Annals of Internal Medicine·P PrandoniM H Prins
Dec 15, 2000·The New England Journal of Medicine·R H WhiteP S Romano
Nov 13, 2001·Mayo Clinic Proceedings·J A HeitW M O'Fallon
Mar 29, 2002·The New England Journal of Medicine·David BergqvistUNKNOWN ENOXACAN II Investigators
Jun 1, 2002·Archives of Internal Medicine·John A HeitL Joseph Melton
Dec 25, 2003·Thrombosis Research·Sherali A RahimJeffrey Ginsberg
Jan 13, 2004·The American Journal of Cardiology·Samuel Z GoldhaberUNKNOWN DVT FREE Steering Committee
Mar 6, 2004·Journal of Thrombosis and Haemostasis : JTH·A K KakkarUNKNOWN Investigators Against Thromboembolism (INATE) Core Group
Jun 18, 2004·The New England Journal of Medicine·Paul A KyrleSabine Eichinger
Mar 1, 2005·Journal of Thrombosis and Haemostasis : JTH·S R KahnUNKNOWN Extended Low-intensity Anticoagulation for Thrombo-embolism (ELATE) Investigators
Mar 11, 2005·The New England Journal of Medicine·Nils KucherSamuel Z Goldhaber
Jul 13, 2005·Archives of Internal Medicine·Victor F TapsonUNKNOWN NABOR (National Anticoagulation Benchmark and Outcomes Report) Steering Committee
Jul 22, 2005·The New England Journal of Medicine·Scott C WilliamsJerod M Loeb
Oct 26, 2005·Journal of Vascular Surgery·Joseph A CapriniUNKNOWN NABOR Steering Committee
Jun 29, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dale W Bratzler, David R Hunt
Jan 16, 2007·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Sylvia McKeanLarry Wellikson
Jan 30, 2007·The New England Journal of Medicine·Peter K LindenauerDale W Bratzler
May 15, 2007·Current Opinion in Infectious Diseases·Dale W BratzlerPeter M Houck
May 24, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Edith A Nutescu
Oct 17, 2007·Thrombosis and Haemostasis·Alexander T CohenUNKNOWN VTE Impact Assessment Group in Europe (VITAE)
Feb 12, 2008·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Lee Ann Krapfl, Dianne Mackey
Feb 26, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·John A Heit
Jun 4, 2008·Critical Pathways in Cardiology·Cassidy S SmithMori J Krantz
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Feb 19, 2009·British Journal of Haematology·Paolo Prandoni, Susan R Kahn
Mar 31, 2009·Journal of the American Dietetic Association·Steven K Galson

❮ Previous
Next ❯

Citations

Sep 12, 2013·Journal of Thrombosis and Thrombolysis·G Eymin, A K Jaffer
Mar 1, 2012·Journal of Medical Economics·Charles Mahan, Alex C Spyropoulos
Jan 15, 2013·Journal of the American College of Surgeons·M Francesca MonnSusan L Gearhart
May 12, 2016·Journal of Graduate Medical Education·Syed Ahmed HussainSuzanne R White
May 26, 2011·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Victor F TapsonRandy Weeks
Jan 21, 2012·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Maureen A SmytheRajul Parikh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.